A detailed history of Loomis Sayles & CO L P transactions in Novartis Ag stock. As of the latest transaction made, Loomis Sayles & CO L P holds 5,917,972 shares of NVS stock, worth $635 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
5,917,972
Previous 6,009,900 1.53%
Holding current value
$635 Million
Previous $607 Million 5.66%
% of portfolio
0.81%
Previous 0.93%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$95.27 - $108.47 $8.76 Million - $9.97 Million
-91,928 Reduced 1.53%
5,917,972 $572 Million
Q4 2023

Feb 13, 2024

SELL
$92.27 - $101.54 $5.23 Million - $5.76 Million
-56,717 Reduced 0.93%
6,009,900 $607 Million
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $23.5 Million - $26.1 Million
-248,393 Reduced 3.93%
6,066,617 $618 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $27 Million - $30.6 Million
-292,139 Reduced 4.42%
6,315,010 $637 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $347 Million - $403 Million
-4,338,849 Reduced 39.64%
6,607,149 $608 Million
Q4 2022

Feb 10, 2023

SELL
$75.55 - $92.52 $301 Million - $369 Million
-3,983,754 Reduced 26.68%
10,945,998 $993 Million
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $41.4 Million - $48.5 Million
-555,468 Reduced 3.59%
14,929,752 $1.13 Billion
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $147 Million - $171 Million
-1,821,967 Reduced 10.53%
15,485,220 $1.31 Billion
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $47 Million - $53.1 Million
-586,379 Reduced 3.28%
17,307,187 $1.52 Billion
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $83.4 Million - $92.2 Million
-1,045,879 Reduced 5.52%
17,893,566 $1.57 Billion
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $6.55 Million - $7.62 Million
-80,144 Reduced 0.42%
18,939,445 $1.55 Billion
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $63.9 Million - $70.5 Million
-749,188 Reduced 3.79%
19,019,589 $1.74 Billion
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $29.1 Million - $34.4 Million
-348,952 Reduced 1.73%
19,768,777 $1.69 Billion
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $750 Million - $908 Million
9,611,979 Added 91.49%
20,117,729 $1.9 Billion
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $3.15 Million - $3.49 Million
-38,369 Reduced 0.36%
10,505,750 $914 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $11 Million - $12.4 Million
136,363 Added 1.31%
10,544,119 $921 Million
Q1 2020

May 15, 2020

BUY
$70.67 - $99.01 $10.1 Million - $14.1 Million
142,624 Added 1.39%
10,407,756 $858 Million
Q4 2019

Feb 14, 2020

BUY
$84.35 - $95.37 $267 Million - $302 Million
3,162,317 Added 44.52%
10,265,132 $972 Million
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $6.39 Million - $7.04 Million
74,679 Added 1.06%
7,102,815 $617 Million
Q2 2019

Aug 14, 2019

BUY
$75.4 - $92.8 $1.27 Million - $1.56 Million
16,801 Added 0.24%
7,028,136 $642 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $3.55 Million - $4.07 Million
47,186 Added 0.68%
7,011,335 $674 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $28.1 Million - $31.3 Million
-381,770 Reduced 5.2%
6,964,149 $598 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $9.12 Million - $10.5 Million
136,220 Added 1.89%
7,345,919 $633 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $38.5 Million - $43.5 Million
-592,387 Reduced 7.59%
7,209,699 $545 Million
Q1 2018

May 11, 2018

BUY
$70.39 - $84.15 $62.4 Million - $74.7 Million
887,198 Added 12.83%
7,802,086 $631 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $8.3 Million - $8.91 Million
114,781 Added 1.69%
6,914,888 $581 Million
Q3 2017

Nov 14, 2017

BUY
$74.14 - $77.27 $12.5 Million - $13 Million
168,494 Added 2.54%
6,800,107 $584 Million
Q2 2017

Aug 14, 2017

BUY
N/A
6,631,613
6,631,613 $554 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $231B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.